
Become part of a vital chain and contribute to our common goal of making people’s lives better. Octapharma is one of the largest human protein manufacturers in the world, developing and producing medicines sourced from human plasma and human cell lines. We are a privately-owned company, where the warmth of family meets the scale of a global organisation.
Octapharma AB is located in northwestern Kungsholmen in Stockholm and has approximately 1,100 employees.
Join us in shaping our vision to provide new health solutions advancing human life.
This position is tied to the 2-year International Early Career Program, that can support you to kick-start a career at Octapharma via international intra-group rotations and developmental sessions. See more program information here (länk International Early Career Program)
This position is based at our production site in Stockholm, and during the first two years you will take part in 2–3 rotations of approximately 1–3 months each at our other production sites in Europe.
We live diversity and stand for equal opportunities as an employer! We therefore look forward to receiving your application - regardless of age, gender, origin, sexual orientation, and religion.
Read more about Unit and follow our day‑to‑day updates on LinkedIn
If you have any questions about the position, please contact Josefina Kihlström (Recruitment Lead) at josefina.kihlström@octapharma.com
For this position, we have chosen to manage the recruitment ourselves and therefore kindly ask recruitment agencies not to contact us.
Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. We employ more than 11,000 people worldwide to support the treatment of patients in 120 countries with products across
For this position, we have chosen to manage the recruitment process internally and therefore kindly ask recruitment agencies to refrain from contacting us.

Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines.
Octapharma employs more than 11,000 people worldwide to support the treatment of patients in 120 countries with products across three therapeutic areas: Immunotherapy, Haematology and Critical Care.
Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates over 195 plasma donation centres across Europe and the US. Octapharma has more than 40 years of experience in patient care.
Check our community guidelines: https://bit.ly/3M8ioml